^
Association details:
| Biomarker: | HER-2 positive |
|---|---|
| Cancer: | HER2 Positive Breast Cancer |
| Drug Class: | HER2-targeted CAR-T immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
149 In vitro efficacy studies to support engineered T cell therapies
Published date:
11/09/2021
Excerpt:
HER2 CAR-T cells efficiently reduced the viability of the HER2-positive cell line ZR-75-30...the HER2 CAR-T cells persistently killed HER2-positive tumor cells, indicative of ‘cellular fitness.
DOI:
http://dx.doi.org/10.1136/jitc-2021-SITC2021.149
